On-Demand webinar
Summary:
Join Siemens Healthineers and world-renowned cardiac expert Professor Dr. Fred Apple. Learn about the latest guidelines including the controversial 2020 European Society for Cardiology (ESC) NSTEMI guidelines and the NICE guidelines. Professor Apple will discuss why the 2020 ESC NSTEMI guidelines may be considered controversial and will share his hard-hitting interpretation perspectives and review of the evidence.
Speaking on these findings, Dr. Fred Apple, Ph.D. Medical Director of Clinical Laboratories at Hennepin County Medical Center, will help you:
- Discuss the latest guidelines including the controversial 2020 ESC NSTEMI guidelines and the NICE guidelines
- Understand why the 2020 ESC NSTEMI guidelines are controversial with hard-hitting interpretation perspectives from Prof. Apple including a biased reference compendium and misguided 99th percentile figure
- Understand the early rule out and rule in strategies using high sensitivity cardiac troponin testing
Speaker:
Fred S. Apple, Ph.D., DABCC
Medical Director of Clinical Laboratories
Hennepin County Medical Center
Prof. Apple’s research interests have centered in the areas of cardiac biomarkers in acute coronary syndrome and heart failure. His CLIA-certified research laboratory is the “Cardiac Biomarker Trials Lab” at the Hennepin Healthcare Research Institute of Hennepin County Medical Center/Hennepin Healthcare. Prof. Apple is a Professor of Laboratory Medicine & Pathology at the University of Minnesota. He has served as an associate editor of Clinical Chemistry for the past 20 years. He also serves as a member of the global task force on the universal definition of myocardial infarction and myocardial injury, chair of the IFCC committee on clinical applications of cardiac biomarkers, member of the AACC Academy committee on laboratory medicine practice guidelines for myocardial infarction and heart failure, and member of the AACC Clinical Societies Collaboration Committee. He is on the steering committee of the British Heart Foundation High STEACS trial. He has also served on the Institute of Medicine’s committee on biomarkers as surrogate endpoints of chronic disease risk and on the National Heart, Lung, and Blood Institute working group for onsite tools and technologies for clinical cardiovascular research and point-of-care. He is the program co-director of the clinical chemistry COMACC fellowship at the Hennepin County Medical Center.
